A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

NCT01089660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Swine-origin A/H1N1 Influenza

Interventions

BIOLOGICAL: Swine A/H1N1 influenza vaccine (split virion, inactivated)
BIOLOGICAL: Swine A/H1N1 influenza vaccine (split virion, inactivated)

Sponsor

Sanofi Pasteur, a Sanofi Company